Cure My Disease

Don't miss your cure!

 Log in / Sign up

Red flag system aims to prevent fainting during office hysteroscopy

NCT ID NCT07030218

Knowledge-focused Sponsor: Tanvir Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This study tests a new 'red flag' classification system to predict which women might faint or feel faint during office hysteroscopy, a procedure where a small camera is inserted into the uterus. Researchers will monitor 100 women for signs of distress and pain during the procedure, comparing their experience to normal menstrual pain. The goal is to see if this simple checklist can help doctors improve safety and comfort for future patients.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to a simple checklist that helps doctors identify women at risk of fainting during hysteroscopy, making the procedure safer.
What could go wrong
This is a small pilot study with only 100 participants, so the red flag system may not work as well in larger, more diverse groups. It is designed to test feasibility, not to prove effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2025

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

women undergoing office hysteroscopy in the hospital / outpatient

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women ≥18 years * Prior gynecological care * Informed consent provided Exclusion Criteria: * Inability to consent * Psychiatric disorders or anxiolytic use * Use of dilators or anesthesia above level 3a * Family history of VVS

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Presyncope are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Syncope syncope, familial vasovagal Syncope, Vasovagal

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Presyncope Vasovagal syncope (VVS)

Contacts and locations

Locations

  • Tanvir Hospital

    Hyderabad, Telangana, 500073, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.